Abbott (ABT) Introduces Biowearables at CES
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/24/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- Americold to wind down Ahold Delhaize facilities, take $305M charge
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Wall St falls as tech earnings spark AI spending worries and oil hits $100
- Did Google and Tesla just break AI trade’s bull case?
Abbott Announces Future of Biowearables at Consumer Electronics Show
January 6, 2022 1:15 PM ESTLAS VEGAS, Jan. 6, 2022 /PRNewswire/ -- Making CES history, Abbott (NYSE: ABT) presented a keynote at the most influential tech event in the world, the first healthcare company ever to do so.
Abbott Chairman and Chief Executive Officer Robert B. Ford headlined the event, "Human-Powered Health: Unlocking the Possibility of You."
"Technology gives us the power to digitize, decentralize and democratize healthcare, create a shared language between you and your doctor and put more control of your health in your hands," Mr. Ford said. "We're creating a... More
